COVID-19 Prevention: Vitamin D Is Still a Valid Remedy
Rachel Nicoll, Michael Y Henein
Journal of Clinical Medicine, doi:10.3390/jcm11226818
Seven meta-analyses and systematic reviews and three later clinical trials argued that low vitamin D status increased susceptibility to COVID-19 and the risk of greater disease severity and mortality [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . Furthermore, there are five meta-analyses and systematic reviews of vitamin D supplementation for the prevention of acute respiratory infection (ARI) [11, 12] and , as well as a later clinical trial [16], all showing that supplementation can protect against COVID-19 infection, disease severity, and death. The evidence could not be much more conclusive than this. Consequently, it was surprising to learn about Joliffe et al.'s recent randomized controlled trial of vitamin D to prevent ARIs and COVID-19, which concluded that 'Among people aged 16 years and older with suboptimal vitamin D status, implementation of a population level test-and-treat approach to vitamin D supplementation was not associated with a reduction in risk of all cause acute respiratory tract infection or . Joliffe et al.'s UK study was a test-and-treat approach used to determine the effect of correcting suboptimal vitamin D status (25-hydroxyvitamin D (25(OH)D) < 75 nmol/L) on the risk of contracting ARIs and COVID-19. Those with 25(OH)D < 75 nmol/L (30 ng/mL) were randomized to six months of supplementary vitamin D at 3200 IU/day, 800 IU/day, or no supplements. The outcome was the percentage of subjects with confirmed ARI/COVID-19. What was different about this trial that might have caused it to fail? Analysis of Joliffe et al's paper gives rise to a number of observations. Of particular importance was the treatment of participants randomized to 'No supplementation'. Instead of being given a placebo, as would be normal in a controlled study, they were given nothing and were informed that it was a vitamin D trial, thereby alerting them to the fact that vitamin D supplementation could be an important infection preventive in the middle of the COVID-19 pandemic. As a result, almost 50% reported taking their own vitamin D supplements. We do not know what level of supplementation these participants took and we can assume that if 50% reported supplementation, the actual number was probably higher. As Dr David Grimes noted in a BMJ Rapid Response, this was therefore 'a randomised UNCONTROLLED study ' [18]; consequently, any comparison of the intervention arm with the 'no supplementation' arm was rendered meaningless. The authors sought to overcome this limitation by conducting sensitivity analysis, but this is no substitute for conducting a properly controlled trial. Furthermore, the authors took the unusual step of retesting those who had baseline vitamin D levels of ≥75 nmol/L (≥30 ng/mL) after 2 months. If they now proved to have vitamin D levels of <75 nmol/L (<30 ng/mL), they were included in the study and supplemented for four months. These new participants amounted to 11% in the lower dose group and 20% in the higher dose..
References
Barrett, Youssef, Shah, Ioana, Lawati et al., Vitamin D Status and Mortality from SARS CoV-2: A Prospective Study of Unvaccinated Caucasian Adults, Nutrients,
doi:10.3390/nu14163252Bergman, Norlin, Hansen, Rekha, Agerberth et al., Vitamin D3 supplementation in patients with frequent respiratory tract infections: A randomised and double-blind intervention study, BMJ Open,
doi:10.1136/bmjopen-2012-001663Borsche, Glauner, Von Mendel, COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis, Nutrients,
doi:10.3390/nu13103596Chiodini, Gatti, Soranna, Merlotti, Mingiano et al., Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes, Front. Public Health
Chiu, Tsai, Wu, Zheng, Yang et al., Putative Role of Vitamin D for COVID-19 Vaccination, Int. J. Mol. Sci,
doi:10.3390/ijms22168988D'ecclesiis, Gavioli, Martinoli, Raimondi, Chiocca et al., Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis, PLoS ONE,
doi:10.1371/journal.pone.0268396Dissanayake, De Silva, Sumanatilleke, De Silva, Gamage et al., Prognostic and Therapeutic Role of Vitamin D in COVID-19: Systematic Review and Meta-analysis, J. Clin. Endocrinol. Metab,
doi:10.1210/clinem/dgab892Ebrahimzadeh, Mohseni, Narimani, Ebrahimzadeh, Kazemi et al., Association between vitamin D status and risk of COVID-19 in-hospital mortality: A systematic review and meta-analysis of observational studies, Crit. Rev. Food Sci. Nutr,
doi:10.1080/10408398.2021.2012419Grant, Boucher, Al Anouti, Pilz, Comparing the Evidence from Observational Studies and Randomized Controlled Trials for Nonskeletal Health Effects of Vitamin D, Nutrients,
doi:10.3390/nu14183811Gönen, Alaylıo Glu, Durcan, Özdemir, Şahin et al., Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1, Nutrients,
doi:10.3390/nu13114047Hanggara, Iskandar, Susianti, Wahono, Pratama et al., The Role of Vitamin D for Modulating the T Helper 1 Immune Response After the Coronavac Vaccination, J. Interferon Cytokine Res,
doi:10.1089/jir.2021.0218Israel, Cicurel, Feldhamer, Stern, Dror et al., Vitamin D deficiency is associated with higher risks for SARS-CoV-2 infection and COVID-19 severity: A retrospective case-control study, Intern. Emerg. Med,
doi:10.1007/s11739-021-02902-wJolliffe, Camargo, Jr, Sluyter, Aglipay et al., Vitamin D supplementation to prevent acute respiratory infections: A systematic review and meta-analysis of aggregate data from randomised controlled trials, Lancet Diabetes Endocrinol
Jolliffe, Holt, Greenig, Talaei, Perdek et al., Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and COVID-19: Phase 3 randomised controlled trial (CORONAVIT), BMJ,
doi:10.1136/bmj-2022-071230Kaya, Pamukçu, Yakar, The role of vitamin D deficiency on COVID-19: A systematic review and meta-analysis of observational studies, Epidemiol. Health,
doi:10.4178/epih.e2021074Kerr, Bedston, Bradley, Joy, Lowthian et al., Waning of first-and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: A pooled target trial study of 12.9 million individuals in England, Int. J. Epidemiol,
doi:10.1093/ije/dyac199Martineau, Jolliffe, Hooper, Greenberg, Aloia et al., Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data, BMJ,
doi:10.1136/bmj.i6583Neves, Pott-Junior, De Sousa Santos, Cominetti, De Melo Freire et al., Vitamin D deficiency predicts 30-day hospital mortality of adults with COVID-19, Clin. Nutr. ESPEN,
doi:10.1016/j.clnesp.2022.05.027Nikniaz, Akbarzadeh, Hosseinifard, Hosseini, The Impact of Vitamin D Supplementation on Mortality Rate and Clinical Outcomes of COVID-19 Patients: A Systematic Review and Meta-Analysis, Pharm. Sci
Oristrell, Oliva, Casado, Subirana, Domínguez et al., Vitamin D supplementation and COVID-19 risk: A population-based, cohort study, J. Endocrinol. Investig,
doi:10.1007/s40618-021-01639-9Piernas, Patone, Astbury, Gao, Sheikh et al., Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: A population-based cohort study, Lancet Diabetes Endocrinol,
doi:10.1016/S2213-8587(22)00158-9Qin, Bouteau, Herbst, Igyártó, Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion, PLoS Pathog,
doi:10.1371/journal.ppat.1010830Sabico, Enani, Sheshah, Aljohani, Aldisi et al., Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial, Nutrients,
doi:10.3390/nu13072170Seal, Bertenthal, Carey, Grunfeld, Bikle et al., Association of Vitamin D Status and COVID-19-Related Hospitalization and Mortality, J. Gen. Intern. Med,
doi:10.1007/s11606-021-07170-0Seneff, Nigh, Kyriakopoulos, Mccullough, Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs, Food Chem. Toxicol,
doi:10.1016/j.fct.2022.113008Szarpak, Rafique, Gasecka, Chirico, Gawel et al., A systematic review and meta-analysis of effect of vitamin D levels on the incidence of COVID-19, Cardiol. J
Tentolouris, Samakidou, Eleftheriadou, Tentolouris, Jude, The effect of vitamin D supplementation on mortality and intensive care unit admission of COVID-19 patients. A systematic review, meta-analysis and meta-regression, Diabetes Metab. Res. Rev,
doi:10.1002/dmrr.3517Teshome, Adane, Girma, Mekonnen, The Impact of Vitamin D Level on COVID-19 Infection: Systematic Review and Meta-Analysis, Front. Public Health,
doi:10.3389/fpubh.2021.624559Villasis-Keever, López-Alarcón, Miranda-Novales, Zurita-Cruz, Barrada-Vázquez et al., Efficacy and Safety of Vitamin D Supplementation to Prevent COVID-19 in Frontline Healthcare Workers. A Randomized Clinical Trial, Arch. Med. Res,
doi:10.1016/j.arcmed.2022.04.003DOI record:
{
"DOI": "10.3390/jcm11226818",
"ISSN": [
"2077-0383"
],
"URL": "http://dx.doi.org/10.3390/jcm11226818",
"abstract": "<jats:p>Seven meta-analyses and systematic reviews and three later clinical trials argued that low vitamin D status increased susceptibility to COVID-19 and the risk of greater disease severity and mortality [...]</jats:p>",
"alternative-id": [
"jcm11226818"
],
"author": [
{
"affiliation": [],
"family": "Nicoll",
"given": "Rachel",
"sequence": "first"
},
{
"ORCID": "http://orcid.org/0000-0002-6089-5614",
"affiliation": [],
"authenticated-orcid": false,
"family": "Henein",
"given": "Michael Y.",
"sequence": "additional"
}
],
"container-title": "Journal of Clinical Medicine",
"container-title-short": "JCM",
"content-domain": {
"crossmark-restriction": false,
"domain": []
},
"created": {
"date-parts": [
[
2022,
11,
18
]
],
"date-time": "2022-11-18T11:02:29Z",
"timestamp": 1668769349000
},
"deposited": {
"date-parts": [
[
2022,
11,
18
]
],
"date-time": "2022-11-18T12:46:31Z",
"timestamp": 1668775591000
},
"indexed": {
"date-parts": [
[
2022,
11,
19
]
],
"date-time": "2022-11-19T06:03:03Z",
"timestamp": 1668837783945
},
"is-referenced-by-count": 0,
"issue": "22",
"issued": {
"date-parts": [
[
2022,
11,
18
]
]
},
"journal-issue": {
"issue": "22",
"published-online": {
"date-parts": [
[
2022,
11
]
]
}
},
"language": "en",
"license": [
{
"URL": "https://creativecommons.org/licenses/by/4.0/",
"content-version": "vor",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2022,
11,
18
]
],
"date-time": "2022-11-18T00:00:00Z",
"timestamp": 1668729600000
}
}
],
"link": [
{
"URL": "https://www.mdpi.com/2077-0383/11/22/6818/pdf",
"content-type": "unspecified",
"content-version": "vor",
"intended-application": "similarity-checking"
}
],
"member": "1968",
"original-title": [],
"page": "6818",
"prefix": "10.3390",
"published": {
"date-parts": [
[
2022,
11,
18
]
]
},
"published-online": {
"date-parts": [
[
2022,
11,
18
]
]
},
"publisher": "MDPI AG",
"reference": [
{
"DOI": "10.1210/clinem/dgab892",
"article-title": "Prognostic and Therapeutic Role of Vitamin D in COVID-19: Systematic Review and Meta-analysis",
"doi-asserted-by": "crossref",
"first-page": "1484",
"journal-title": "J. Clin. Endocrinol. Metab.",
"key": "ref_1",
"volume": "107",
"year": "2022"
},
{
"DOI": "10.5603/CJ.a2021.0072",
"article-title": "A systematic review and meta-analysis of effect of vitamin D levels on the incidence of COVID-19",
"doi-asserted-by": "crossref",
"first-page": "647",
"journal-title": "Cardiol. J.",
"key": "ref_2",
"volume": "28",
"year": "2021"
},
{
"DOI": "10.2478/sjph-2022-0017",
"article-title": "COVID-19 and Vitamin D—A Systematic Review",
"doi-asserted-by": "crossref",
"first-page": "124",
"journal-title": "Slov. J. Public Health",
"key": "ref_3",
"volume": "61",
"year": "2022"
},
{
"DOI": "10.4178/epih.e2021074",
"article-title": "The role of vitamin D deficiency on COVID-19: A systematic review and meta-analysis of observational studies",
"doi-asserted-by": "crossref",
"first-page": "e2021074",
"journal-title": "Epidemiol. Health",
"key": "ref_4",
"volume": "43",
"year": "2021"
},
{
"DOI": "10.3389/fpubh.2021.624559",
"article-title": "The Impact of Vitamin D Level on COVID-19 Infection: Systematic Review and Meta-Analysis",
"doi-asserted-by": "crossref",
"first-page": "624559",
"journal-title": "Front. Public Health",
"key": "ref_5",
"volume": "9",
"year": "2021"
},
{
"DOI": "10.1080/10408398.2021.2012419",
"doi-asserted-by": "crossref",
"key": "ref_6",
"unstructured": "Ebrahimzadeh, A., Mohseni, S., Narimani, B., Ebrahimzadeh, A., Kazemi, S., Keshavarz, F., Yaghoubi, M.J., and Milajerdi, A. (2021). Association between vitamin D status and risk of COVID-19 in-hospital mortality: A systematic review and meta-analysis of observational studies. Crit. Rev. Food Sci. Nutr., 1–11."
},
{
"DOI": "10.1101/2021.09.22.21263977",
"doi-asserted-by": "crossref",
"key": "ref_7",
"unstructured": "Borsche, L., Glauner, B., and von Mendel, J. (2021). COVID-19 Mortality Risk Correlates Inversely with Vitamin D3 Status, and a Mortality Rate Close to Zero Could Theoretically Be Achieved at 50 ng/mL 25(OH)D3: Results of a Systematic Review and Meta-Analysis. Nutrients, 13."
},
{
"DOI": "10.1016/j.clnesp.2022.05.027",
"article-title": "Vitamin D deficiency predicts 30-day hospital mortality of adults with COVID-19",
"doi-asserted-by": "crossref",
"first-page": "322",
"journal-title": "Clin. Nutr. ESPEN",
"key": "ref_8",
"volume": "50",
"year": "2022"
},
{
"DOI": "10.3390/nu14163252",
"doi-asserted-by": "crossref",
"key": "ref_9",
"unstructured": "Barrett, R., Youssef, M., Shah, I., Ioana, J., Lawati, A.A., Bukhari, A., Hegarty, S., Cormican, L.J., Judge, E., and Burke, C.M. (2022). Vitamin D Status and Mortality from SARS CoV-2: A Prospective Study of Unvaccinated Caucasian Adults. Nutrients, 14."
},
{
"DOI": "10.1007/s11739-021-02902-w",
"article-title": "Vitamin D deficiency is associated with higher risks for SARS-CoV-2 infection and COVID-19 severity: A retrospective case-control study",
"doi-asserted-by": "crossref",
"first-page": "1053",
"journal-title": "Intern. Emerg. Med.",
"key": "ref_10",
"volume": "17",
"year": "2022"
},
{
"article-title": "Vitamin D supplementation to prevent acute respiratory tract infections: Systematic review and meta-analysis of individual participant data",
"first-page": "i6583",
"journal-title": "BMJ",
"key": "ref_11",
"volume": "356",
"year": "2017"
},
{
"DOI": "10.1016/S2213-8587(21)00051-6",
"article-title": "Vitamin D supplementation to prevent acute respiratory infections: A systematic review and meta-analysis of aggregate data from randomised controlled trials",
"doi-asserted-by": "crossref",
"first-page": "276",
"journal-title": "Lancet Diabetes Endocrinol.",
"key": "ref_12",
"volume": "9",
"year": "2021"
},
{
"DOI": "10.1371/journal.pone.0268396",
"doi-asserted-by": "crossref",
"key": "ref_13",
"unstructured": "D’Ecclesiis, O., Gavioli, C., Martinoli, C., Raimondi, S., Chiocca, S., Miccolo, C., Bossi, P., Cortinovis, D., Chiaradonna, F., and Palorini, R. (2022). Vitamin D and SARS-CoV2 infection, severity and mortality: A systematic review and meta-analysis. PLoS ONE, 17."
},
{
"article-title": "The effect of vitamin D supplementation on mortality and intensive care unit admission of COVID-19 patients. A systematic review, meta-analysis and meta-regression",
"first-page": "e3517",
"journal-title": "Diabetes Metab. Res. Rev.",
"key": "ref_14",
"volume": "38",
"year": "2022"
},
{
"article-title": "The Impact of Vitamin D Supplementation on Mortality Rate and Clinical Outcomes of COVID-19 Patients: A Systematic Review and Meta-Analysis",
"first-page": "S1",
"journal-title": "Pharm. Sci.",
"key": "ref_15",
"volume": "27",
"year": "2021"
},
{
"key": "ref_16",
"unstructured": "(2022, November 16). Effect of Vitamin D3 Supplementation vs. Dietary-Hygienic Measures on SARS-COV-2 Infection Rates in Hospital Workers with 25-Hydroxyvitamin D3 [25(OH)D3] Levels ≥20 ng/mL. Available online: https://www.medrxiv.org/content/10.1101/2022.07.12.22277450v1."
},
{
"article-title": "Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and COVID-19: Phase 3 randomised controlled trial (CORONAVIT)",
"first-page": "e071230",
"journal-title": "BMJ",
"key": "ref_17",
"volume": "378",
"year": "2022"
},
{
"DOI": "10.1136/bmj-2022-071230",
"doi-asserted-by": "crossref",
"key": "ref_18",
"unstructured": "(2022, November 16). Rapid Response to: Effect of a Test-and-Treat Approach to Vitamin D Supplementation on Risk of all Cause Acute Respiratory Tract Infection and COVID-19: Phase 3 Randomised Controlled Trial (CORONAVIT). Available online: https://www.bmj.com/content/378/bmj-2022-071230/rr."
},
{
"DOI": "10.3389/fpubh.2021.736665",
"article-title": "Vitamin D Status and SARS-CoV-2 Infection and COVID-19 Clinical Outcomes",
"doi-asserted-by": "crossref",
"first-page": "736665",
"journal-title": "Front. Public Health",
"key": "ref_19",
"volume": "9",
"year": "2021"
},
{
"DOI": "10.1007/s11606-021-07170-0",
"article-title": "Association of Vitamin D Status and COVID-19-Related Hospitalization and Mortality",
"doi-asserted-by": "crossref",
"first-page": "853",
"journal-title": "J. Gen. Intern. Med.",
"key": "ref_20",
"volume": "37",
"year": "2022"
},
{
"DOI": "10.1136/bmjopen-2012-001663",
"article-title": "Vitamin D3 supplementation in patients with frequent respiratory tract infections: A randomised and double-blind intervention study",
"doi-asserted-by": "crossref",
"first-page": "e001663",
"journal-title": "BMJ Open",
"key": "ref_21",
"volume": "2",
"year": "2012"
},
{
"DOI": "10.1016/j.arcmed.2022.04.003",
"article-title": "Efficacy and Safety of Vitamin D Supplementation to Prevent COVID-19 in Frontline Healthcare Workers. A Randomized Clinical Trial",
"doi-asserted-by": "crossref",
"first-page": "423",
"journal-title": "Arch. Med. Res.",
"key": "ref_22",
"volume": "53",
"year": "2022"
},
{
"DOI": "10.3390/nu13072170",
"doi-asserted-by": "crossref",
"key": "ref_23",
"unstructured": "Sabico, S., Enani, M.A., Sheshah, E., Aljohani, N.J., Aldisi, D.A., Alotaibi, N.H., Alshingetti, N., Alomar, S.Y., Alnaami, A.M., and Amer, O.E. (2021). Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial. Nutrients, 13."
},
{
"DOI": "10.3390/nu13114047",
"doi-asserted-by": "crossref",
"key": "ref_24",
"unstructured": "Gönen, M.S., Alaylıoğlu, M., Durcan, E., Özdemir, Y., Şahin, S., Konukoğlu, D., Nohut, O.K., Ürkmez, S., Küçükece, B., and Balkan, İ.İ. (2021). Rapid and Effective Vitamin D Supplementation May Present Better Clinical Outcomes in COVID-19 (SARS-CoV-2) Patients by Altering Serum INOS1, IL1B, IFNg, Cathelicidin-LL37, and ICAM1. Nutrients, 13."
},
{
"DOI": "10.1007/s40618-021-01639-9",
"article-title": "Vitamin D supplementation and COVID-19 risk: A population-based, cohort study",
"doi-asserted-by": "crossref",
"first-page": "167",
"journal-title": "J. Endocrinol. Investig.",
"key": "ref_25",
"volume": "45",
"year": "2022"
},
{
"DOI": "10.3390/nu14183811",
"doi-asserted-by": "crossref",
"key": "ref_26",
"unstructured": "Grant, W.B., Boucher, B.J., Al Anouti, F., and Pilz, S. (2022). Comparing the Evidence from Observational Studies and Randomized Controlled Trials for Nonskeletal Health Effects of Vitamin D. Nutrients, 14."
},
{
"DOI": "10.1101/2022.03.16.484616",
"doi-asserted-by": "crossref",
"key": "ref_27",
"unstructured": "Qin, Z., Bouteau, A., Herbst, C., and Igyártó, B.Z. (2022). Pre-exposure to mRNA-LNP inhibits adaptive immune responses and alters innate immune fitness in an inheritable fashion. PLoS Pathog., 18."
},
{
"key": "ref_28",
"unstructured": "(2022, November 02). The BNT162b2 mRNA Vaccine Against SARS-CoV-2 Reprograms both Adaptive and Innate Immune Responses. Available online: https://www.medrxiv.org/content/10.1101/2021.05.03.21256520v1.full."
},
{
"DOI": "10.1016/j.fct.2022.113008",
"article-title": "Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs",
"doi-asserted-by": "crossref",
"first-page": "113008",
"journal-title": "Food Chem. Toxicol.",
"key": "ref_29",
"volume": "164",
"year": "2022"
},
{
"DOI": "10.3390/ijms22168988",
"doi-asserted-by": "crossref",
"key": "ref_30",
"unstructured": "Chiu, S.-K., Tsai, K.-W., Wu, C.-C., Zheng, C.-M., Yang, C.-H., Hu, W.-C., Hou, Y.-C., Lu, K.-C., and Chao, Y.-C. (2021). Putative Role of Vitamin D for COVID-19 Vaccination. Int. J. Mol. Sci., 22."
},
{
"DOI": "10.1089/jir.2021.0218",
"article-title": "The Role of Vitamin D for Modulating the T Helper 1 Immune Response After the Coronavac Vaccination",
"doi-asserted-by": "crossref",
"first-page": "329",
"journal-title": "J. Interferon Cytokine Res.",
"key": "ref_31",
"volume": "42",
"year": "2022"
},
{
"DOI": "10.1016/S2213-8587(22)00158-9",
"article-title": "Associations of BMI with COVID-19 vaccine uptake, vaccine effectiveness, and risk of severe COVID-19 outcomes after vaccination in England: A population-based cohort study",
"doi-asserted-by": "crossref",
"first-page": "571",
"journal-title": "Lancet Diabetes Endocrinol.",
"key": "ref_32",
"volume": "10",
"year": "2022"
},
{
"DOI": "10.1093/ije/dyac199",
"doi-asserted-by": "crossref",
"key": "ref_33",
"unstructured": "Kerr, S., Bedston, S., Bradley, D.T., Joy, M., Lowthian, E., Mulholland, R.M., Akbari, A., Hobbs, F.D.R., Katikireddi, S.V., and de Lusignan, S. (2022). Waning of first- and second-dose ChAdOx1 and BNT162b2 COVID-19 vaccinations: A pooled target trial study of 12.9 million individuals in England, Northern Ireland, Scotland and Wales. Int. J. Epidemiol., dyac199."
},
{
"key": "ref_34",
"unstructured": "(2022, November 02). Effectiveness of mRNA-1273 Against Infection and COVID-19 Hospitalization with SARS-CoV-2 Omicron Subvariants: BA.1, BA.2, BA.2.12.1, BA.4, and BA.5. Available online: https://www.medrxiv.org/content/10.1101/2022.09.30.22280573v1."
},
{
"key": "ref_35",
"unstructured": "(2022, November 02). Effectiveness of COVID-19 Vaccines Over 13 Months Covering the Period of the Emergence of the Omicron Variant in the Swedish Population. Available online: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4224504."
},
{
"key": "ref_36",
"unstructured": "(2022, November 02). Atypical B Cells and Impaired SARS-CoV-2 Neutralisation Following Booster Vaccination in the Elderly. Available online: https://www.medrxiv.org/content/10.1101/2022.10.13.22281024v1."
}
],
"reference-count": 36,
"references-count": 36,
"relation": {},
"resource": {
"primary": {
"URL": "https://www.mdpi.com/2077-0383/11/22/6818"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [
"General Medicine"
],
"subtitle": [],
"title": "COVID-19 Prevention: Vitamin D Is Still a Valid Remedy",
"type": "journal-article",
"volume": "11"
}
